Literature DB >> 23910594

Fluorescence detection of cationic amyloid fibrils in human semen.

David Easterhoff1, John T M DiMaio, Wathsala Liyanage, Chi-Wen Lo, Woori Bae, Todd M Doran, Alan Smrcka, Bradley L Nilsson, Stephen Dewhurst.   

Abstract

Cationic amyloid fibrils, including the Semen Enhancer of Virus Infection (SEVI), have recently been described in human semen. Simple methods for quantitating these fibrils are needed to improve our understanding of their biological function. We performed high-throughput screening to identify molecules that bind SEVI, and identified a small molecule (8E2), that fluoresced brightly in the presence of SEVI and other cationic fibrils. 8E2 bound SEVI with almost 40-fold greater affinity than thioflavin-T, and could efficiently detect high molecular weight fibrils in human seminal fluid.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Amyloid; Fluorescence; SEVI; Semen; Thioflavin T

Mesh:

Substances:

Year:  2013        PMID: 23910594      PMCID: PMC3895278          DOI: 10.1016/j.bmcl.2013.06.097

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

1.  Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection.

Authors:  Franziska Arnold; Jacqueline Schnell; Onofrio Zirafi; Christina Stürzel; Christoph Meier; Tanja Weil; Ludger Ständker; Wolf-Georg Forssmann; Nadia R Roan; Warner C Greene; Frank Kirchhoff; Jan Münch
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

2.  The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency.

Authors:  Jeffrey R Brender; Ravi Prakash Reddy Nanga; Nataliya Popovych; Ronald Soong; Peter M Macdonald; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2011-01-22

3.  Alternative pathways of human islet amyloid polypeptide aggregation distinguished by (19)f nuclear magnetic resonance-detected kinetics of monomer consumption.

Authors:  Yuta Suzuki; Jeffrey R Brender; Kevin Hartman; Ayyalusamy Ramamoorthy; E Neil G Marsh
Journal:  Biochemistry       Date:  2012-10-01       Impact factor: 3.162

4.  Enhancement of HIV-1 infectivity by simple, self-assembling modular peptides.

Authors:  David Easterhoff; John T M DiMaio; Todd M Doran; Stephen Dewhurst; Bradley L Nilsson
Journal:  Biophys J       Date:  2011-03-02       Impact factor: 4.033

5.  The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection.

Authors:  Ilona Hauber; Heinrich Hohenberg; Barbara Holstermann; Werner Hunstein; Joachim Hauber
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-18       Impact factor: 11.205

6.  Molecular mechanism of thioflavin-T binding to the surface of beta-rich peptide self-assemblies.

Authors:  Matthew Biancalana; Koki Makabe; Akiko Koide; Shohei Koide
Journal:  J Mol Biol       Date:  2008-11-14       Impact factor: 5.469

7.  The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection.

Authors:  Nadia R Roan; Jan Münch; Nathalie Arhel; Walther Mothes; Jason Neidleman; Akiko Kobayashi; Karen Smith-McCune; Frank Kirchhoff; Warner C Greene
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

8.  EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers.

Authors:  Dagmar E Ehrnhoefer; Jan Bieschke; Annett Boeddrich; Martin Herbst; Laura Masino; Rudi Lurz; Sabine Engemann; Annalisa Pastore; Erich E Wanker
Journal:  Nat Struct Mol Biol       Date:  2008-05-30       Impact factor: 15.369

9.  Thioflavin T as a molecular rotor: fluorescent properties of thioflavin T in solvents with different viscosity.

Authors:  Vitali I Stsiapura; Alexander A Maskevich; Valery A Kuzmitsky; Vladimir N Uversky; Irina M Kuznetsova; Konstantin K Turoverov
Journal:  J Phys Chem B       Date:  2008-12-11       Impact factor: 2.991

10.  Semen-derived amyloid fibrils drastically enhance HIV infection.

Authors:  Jan Münch; Elke Rücker; Ludger Ständker; Knut Adermann; Christine Goffinet; Michael Schindler; Steffen Wildum; Raghavan Chinnadurai; Devi Rajan; Anke Specht; Guillermo Giménez-Gallego; Pedro Cuevas Sánchez; Douglas M Fowler; Atanas Koulov; Jeffery W Kelly; Walther Mothes; Jean-Charles Grivel; Leonid Margolis; Oliver T Keppler; Wolf-Georg Forssmann; Frank Kirchhoff
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

View more
  5 in total

1.  ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.

Authors:  Tianrong Xun; Wenjuan Li; Jinquan Chen; Fei Yu; Wei Xu; Qian Wang; Ruizhe Yu; Xiaojuan Li; Xuefeng Zhou; Lu Lu; Shibo Jiang; Lin Li; Suiyi Tan; Shuwen Liu
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

2.  Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues.

Authors:  Shannon A Allen; Ann M Carias; Meegan R Anderson; Eneniziaogochukwu A Okocha; Lorie Benning; Michael D McRaven; Z L Kelley; John Lurain; Ronald S Veazey; Thomas J Hope
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

3.  Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel Amytracker™ stains.

Authors:  Etheresia Pretorius; Martin J Page; Lisa Hendricks; Nondumiso B Nkosi; Sven R Benson; Douglas B Kell
Journal:  J R Soc Interface       Date:  2018-02       Impact factor: 4.118

4.  Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains.

Authors:  Etheresia Pretorius; Martin J Page; Lize Engelbrecht; Graham C Ellis; Douglas B Kell
Journal:  Cardiovasc Diabetol       Date:  2017-11-02       Impact factor: 9.951

5.  Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen.

Authors:  Shariq M Usmani; Onofrio Zirafi; Janis A Müller; Nathallie L Sandi-Monroy; Jay K Yadav; Christoph Meier; Tanja Weil; Nadia R Roan; Warner C Greene; Paul Walther; K Peter R Nilsson; Per Hammarström; Ronald Wetzel; Christopher D Pilcher; Friedrich Gagsteiger; Marcus Fändrich; Frank Kirchhoff; Jan Münch
Journal:  Nat Commun       Date:  2014-04-01       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.